Merck (NYSE: MRK) and Ridgeback Biotherapeutics have already made a big splash with positive results for their COVID-19 pill. However, there are are other companies nipping at their heels. In this Motley Fool Live video recorded on Oct.
Pfizer (NYSE: PFE) launched the best-selling vaccine Comirnaty with the help of its partner, BioNTech. Merck (NYSE: MRK) is likely to soon have the first COVID-19 pill on the market. Pfizer has delivered greater stock gains than Merck since the beginning of the pandemic.
(Bloomberg) -- Johnson & Johnson’s Covid vaccine booster gained a key recommendation from advisers to the U.S. Food and Drug Administration that brings the additional shot a step closer to clearance.Most Read from BloombergOut-of-Practice Airline Pilots Are Making Errors Back in the AirThe Biggest Public Graveyard in the U.S. Is Becoming a ParkWhy Buying a Second or Even Third Home Is Becoming More Popular Than EverThe World’s Rich and Powerful Are Stashing $500 Billion in This Tax HavenWhat Com